SCHEMBL8625472

SCHEMBL8625472

Cc1ccccc1Oc1ccc(CCCO)cc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 7/20 0.52
LPAR5 Q9H1C0 6/20 0.52
LTA4H P09960 2/20 0.51
EPHX2 P34913 1/20 0.51
FFAR1 O14842 1/20 0.47
PPARA Q07869 1/20 0.44
MAPK14 Q16539 1/20 0.44
ALDH1A1 P00352 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.43
CYP2C19 P33261 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ATM Q13315 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CYP4A11 Q02928 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8623294 0.84 LPAR1 (0.49) LPAR1LPAR5FFAR1MAPK14ALDH1A1
SCHEMBL1746823 0.83 LTA4H (0.60) LPAR1LPAR5LTA4HFFAR1MAPK14
SCHEMBL27871822 0.83 LPAR1 (0.48) LPAR1LPAR5MAPK14ALDH1A1
SCHEMBL2914999 0.80 F2 (0.43)
SCHEMBL18240129 0.79 LTA4H (0.66) LTA4HEPHX2FFAR1PPARAALDH1A1
SCHEMBL30657231 0.79 LTA4H (0.43) LPAR1LPAR5LTA4HEPHX2PPARA
SCHEMBL26636357 0.79 LTA4H (0.43) LPAR1LPAR5LTA4HEPHX2PPARA
1,4-Butanediol SCHEMBL28726461 0.79 MEN1 (0.50) ALDH1A1CYP1A2CYP2C19SMN1; SMN2TDP1
SCHEMBL28862098 0.78 LTA4H (0.58) LTA4HEPHX2FFAR1PPARAALDH1A1
SCHEMBL7690257 0.78 ALDH1A1 (0.59) LPAR1LPAR5LTA4HMAPK14ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5712396-A PHOSPHONOSULFONATE COMPOUNDS USED FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND ATHEROSCLEROSIS MAGNIN DAVID R (US) 1998-01-27 US disclosed
US-5567841-A ANTICHOLESTEROL AGENT BRISTOL-MYERS SQUIBB COMPANY (US) 1996-10-22 US disclosed
US-5470845-A Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia BRISTOL-MYERS SQUIBB COMPANY (US) 1995-11-28 US disclosed